CytomX Therapeutics CTMX Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about CytomX Therapeutics's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CytomX Therapeutics's software and technology licenses, net?
- CytomX Therapeutics (CTMX) reported software and technology licenses, net of $31K in Q1 2026.
- How has CytomX Therapeutics's software and technology licenses, net changed year-over-year?
- CytomX Therapeutics's software and technology licenses, net decreased by 49.2% year-over-year, from $61K to $31K.
- What is the long-term trend for CytomX Therapeutics's software and technology licenses, net?
- Over 5 years (2020 to 2025), CytomX Therapeutics's software and technology licenses, net has grown at a -57.3% compound annual growth rate (CAGR), from $2.17M to $31K.